Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Features

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

Todd Neale

October 22, 2025

News Features

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special

L.A. McKeown

September 25, 2024

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Features

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

Caitlin E. Cox

December 16, 2021

News Features

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

Todd Neale

September 28, 2021

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

L.A. McKeown

December 24, 2020

News Features

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Michael O'Riordan

April 24, 2020

News Features

Obesity and COVID-19: Theories and Blame Fill the Scientific Void

Shelley Wood

April 21, 2020

News Features

Cardiac Rehab During COVID-19: Telehealth, Unpaid Heroes Step Up to Help at Home

L.A. McKeown

April 10, 2020

News Features

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Marcus A. Banks

August 15, 2019

News Features

Sticky Business: Will Taxes on Sugary Sodas Help to Dilute America’s Cardiometabolic Crisis?

Lucy Hicks

August 23, 2018

News Features

Quit This, Start That: How Common New Year’s Resolutions Impact the Heart

Shelley Wood

January 20, 2017

News Features

Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter

Michael O'Riordan

January 10, 2017

News Features

A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity

Yael L. Maxwell

October 24, 2016

News Features

Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways

Michael O'Riordan

October 05, 2016

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

Advertisement

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Obesity and COVID-19: Theories and Blame Fill the Scientific Void

Cardiac Rehab During COVID-19: Telehealth, Unpaid Heroes Step Up to Help at Home

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Sticky Business: Will Taxes on Sugary Sodas Help to Dilute America’s Cardiometabolic Crisis?

Quit This, Start That: How Common New Year’s Resolutions Impact the Heart

Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter

A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity

Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content